Semax N-Acetyl 9mg, Selank N-Acetyl 6mg (15mg Blend)

$74.99

  • Blend: Semax N-Acetyl 9mg / Selank N-Acetyl 6mg
  • Total Content: 15mg
  • Vial Size: 3mL
  • Semax Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂
  • Selank Sequence: Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH
  • Format: Dual-peptide research blend
  • Research Context: Comparative peptide and molecular signaling research
  • Intended Use: Laboratory and in-vitro research only
  • Not intended for human or animal administration

50 in stock

SKU: LPNASMSL15 Categories: , Tags: ,
Description

N-Acetyl Semax 9mg / N-Acetyl Selank 6mg – Advanced 15mg Research Blend

N-acetyl Semax 9mg / N-acetyl Selank 6mg is a 15mg dual-peptide formulation supplied by OROS Research for controlled laboratory investigation. The blend combines two acetylated peptide materials in a single 3mL vial, providing researchers with a defined formulation for comparative and multi-peptide experimental designs.

The Semax component has a supplied molecular weight of 855.0 g/mol, while the Selank component has a supplied molecular weight of 793.9 g/mol. Their different sequences and molecular characteristics make this formulation relevant to research examining distinct peptide structures within a combined experimental system.

N-Acetyl Semax Research Overview

The supplied Semax component has the sequence:

Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂

Its stated molecular formula is C₃₉H₅₄N₁₀O₁₀S, with a molecular weight of 855.0 g/mol and PubChem CID 172638603.

Experimental Semax-related literature has investigated peptide activity in neurological and molecular research contexts. Depending on the experimental model, research areas have included neuronal signaling, neurotrophic-associated pathways, gene-expression responses, and other cellular processes.

These areas represent research contexts rather than established effects of this OROS Research material in humans.

Researchers can consult the supplied Semax PubChem record for available chemical information.

N Acetyl Selank Research Context

The second component, n acetyl selank, is supplied at 6mg with the sequence:

Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH

The supplied molecular formula is C₃₅H₅₉N₁₁O₁₀, with a molecular weight of 793.9 g/mol and PubChem CID 133082488.

Selank-related experimental literature has investigated peptide activity across neurological, molecular, and signaling research models. The N-acetyl modification provides an additional structural characteristic for laboratory investigation.

Researchers can review the supplied Selank PubChem record for available chemical information.

Dual-Peptide Laboratory Research

Combining two distinct peptide materials may support experimental designs involving comparative molecular behavior and multi-component research.

Potential research areas include:

  • Peptide structure-function relationships
  • Comparative peptide analysis
  • Molecular signaling studies
  • Cellular response experiments
  • Peptide stability investigations
  • Neurological research models
  • Gene-expression-associated research
  • Comparative acetylated peptide studies
  • Analytical characterization

The presence of two compounds in one formulation does not establish synergistic therapeutic effects. Any observed interaction must be demonstrated within an appropriately designed experimental model.

Product Specifications

Specification Semax Component Selank Component
Amount 9mg 6mg
Sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂ Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH
Molecular Formula C₃₉H₅₄N₁₀O₁₀S C₃₅H₅₉N₁₁O₁₀
Molecular Weight 855.0 g/mol 793.9 g/mol
PubChem CID 172638603 133082488
CAS Number 2920938-90-3 77591-33-4*

Total Blend: 15mg
Vial Size: 3mL

*CAS information is presented according to the supplied product specifications and should be independently verified for research documentation.

For broader chemical database research, investigators can also use PubChem and search peer-reviewed biomedical literature through PubMed.

N-Acetyl vs Amidate Search Terminology

Researchers may encounter the search phrase n-acetyl semax amidate when investigating modified Semax materials.

The terminology should not automatically be treated as interchangeable with every N-acetyl formulation. Structural modifications, including terminal modifications, can distinguish research materials and should be verified using the exact sequence and specifications associated with the product being studied.

The same principle applies to the phrase n-acetyl selank amidate. Researchers should evaluate the specified molecular structure rather than assuming that all modified forms represent identical compounds.

OROS Research provides Selank N-Acetyl Amidate 10mg as a separate research listing.

A distinct Selank N-Acetyl Amidate Spray 20mg formulation is also available for researchers comparing product formats.

For Semax-related investigation, researchers can separately review Semax N-Acetyl Amidate 30mg.

The dedicated Semax N-Acetyl 9mg / Selank N-Acetyl 6mg 15mg Blend provides the product reference for the formulation described on this page.

Semax for Sale for Laboratory Research

The search phrase semax for sale can represent both legitimate laboratory procurement and searches for personal-use products.

This OROS Research listing concerns research procurement only.

Laboratories evaluating peptide materials should consider the stated sequence, molecular identity, formulation, quantity, documentation, and compatibility with their experimental design.

No personal-use recommendation, administration protocol, or therapeutic claim is associated with this listing.

Scientific Interpretation

Modified peptides should be evaluated according to their exact molecular characteristics.

Acetylation and other structural modifications can be relevant when researchers investigate molecular behavior, stability, receptor interactions, or other experimental characteristics. However, effects observed for one molecular form should not automatically be attributed to another modified form.

Likewise, evidence obtained from cell cultures, animal experiments, or other preclinical systems should not be presented as established human outcomes.

Researchers should evaluate the original methodology, experimental model, endpoints, and limitations of published studies before drawing conclusions about a particular research material.

N-Acetyl Semax FAQ

What is N-acetyl Semax?

It is an acetylated Semax research peptide. The supplied 9mg component has the sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂, molecular formula C₃₉H₅₄N₁₀O₁₀S, and molecular weight 855.0 g/mol.

What does this research blend contain?

The formulation contains 9mg of the Semax component and 6mg of the Selank component, providing a total of 15mg in a 3mL vial.

Are N-acetyl and N-acetyl amidate the same thing?

Researchers should not assume these terms describe identical structures. The exact sequence and terminal modifications of the research material should be checked when comparing different formulations.

What is the purpose of combining the two peptides?

The dual formulation may support appropriately designed comparative or multi-component peptide experiments. Its composition does not by itself establish synergy or a therapeutic benefit.

What is the molecular weight of each component?

According to the supplied specifications, the Semax component has a molecular weight of 855.0 g/mol, while the Selank component has a molecular weight of 793.9 g/mol.

Can researchers purchase this Semax material?

This listing concerns procurement of a laboratory research material. It is supplied exclusively for controlled research and is not intended for self-administration or therapeutic use.

Is this blend intended for human use?

No. It is supplied exclusively for controlled laboratory investigation and is not intended for human or animal consumption, injection, intranasal administration, clinical application, therapeutic use, self-experimentation, or veterinary use.

Research Use Disclaimer

This 15mg dual-peptide formulation is supplied exclusively for controlled laboratory investigation, analytical evaluation, and in-vitro research. It is not intended for human or animal consumption, injection, intranasal administration, clinical application, therapeutic use, diagnosis, performance enhancement, self-administration, or veterinary use. Experimental work should be performed by qualified researchers using appropriately validated laboratory procedures.

Additional information
Net Weight

15mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Semax N-Acetyl 9mg, Selank N-Acetyl 6mg (15mg Blend)”

Your email address will not be published. Required fields are marked *